Condition: Intracerebral Hemorrhage · Sponsor: Beijing Tiantan Hospital
Intracerebral hemorrhage (ICH) is one of the stroke subtypes with the highest global rates of disability and mortality, accounting for 15%-20% of all strokes. Currently, there is a lack of evidence-based interventions for ICH, with treatment primarily relying on supportive care. There is an urgent clinical need to explore new strategies and technologies. The investigators hypothesize that for ICH patients, best medical treatment combined with a non-invasive ultrasonic scalpel (ultrasound Doppler flow analyzer) may be superior to best medical treatment alone. The primary objective of this study is to determine the safety and efficacy of the non-invasive ultrasonic scalpel in promoting hematoma clearance in ICH patients.
This description comes directly from the study's public registry record.
Ruijun Ji · 86 10 5997 5698 · JRJchina@sina.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Wannan Medical University | Wuhu, Anhui, China | Not Yet Recruiting |
| Beijing Fengtai You'anmen Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Beijing Tiantan Hospital of Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07246473